Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. 1998

J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
Protein Phosphorylation Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.

Phosphorylation sites in members of the protein kinase A (PKA), PKG, and PKC kinase subfamily are conserved. Thus, the PKB kinase PDK1 may be responsible for the phosphorylation of PKC isotypes. PDK1 phosphorylated the activation loop sites of PKCzeta and PKCdelta in vitro and in a phosphoinositide 3-kinase (PI 3-kinase)-dependent manner in vivo in human embryonic kidney (293) cells. All members of the PKC family tested formed complexes with PDK1. PDK1-dependent phosphorylation of PKCdelta in vitro was stimulated by combined PKC and PDK1 activators. The activation loop phosphorylation of PKCdelta in response to serum stimulation of cells was PI 3-kinase-dependent and was enhanced by PDK1 coexpression.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D010718 Phosphatidylserines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a SERINE moiety. Serine Phosphoglycerides,Phosphatidyl Serine,Phosphatidyl Serines,Phosphatidylserine,Phosphoglycerides, Serine,Serine, Phosphatidyl,Serines, Phosphatidyl
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations

Related Publications

J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
July 2007, FEBS letters,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
October 2009, The Journal of biological chemistry,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
July 2000, The Journal of biological chemistry,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
March 1997, The Journal of biological chemistry,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
October 2008, Cell cycle (Georgetown, Tex.),
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
August 1992, The Journal of biological chemistry,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
October 1997, Current biology : CB,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
April 2006, Proceedings of the National Academy of Sciences of the United States of America,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
November 2000, FEBS letters,
J A Le Good, and W H Ziegler, and D B Parekh, and D R Alessi, and P Cohen, and P J Parker
April 2013, Journal of medicinal chemistry,
Copied contents to your clipboard!